All data are based on the daily closing price as of February 26, 2026
j

Japan Tobacco

2914.TSE
38.52 USD
-0.32
-0.82%

Overview

Last close
38.52 usd
Market cap
68.39B usd
52 week high
40.16 usd
52 week low
24.55 usd
Target price
38.88 usd

Valuation

P/E
21.5801
Forward P/E
14.9925
Price/Sales
3.1088
Price/Book Value
2.1561
Enterprise Value
60.34B usd
EV/Revenue
2.8403
EV/EBITDA
14.8251

Key financials

Revenue TTM
22.23B usd
Gross Profit TTM
12.49B usd
EBITDA TTM
6.55B usd
Earnings per Share
1.8 usd
Dividend
1.5 usd
Total assets
53.76B usd
Net debt
5.41B usd

About

Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, pharmaceuticals, and processed foods in Japan and internationally. The company operates through three segments: Tobacco Business, Pharmaceutical Business, and Processed Food Business. It offers tobacco products, such as cigarettes, heat-not-burn tobacco products, E-vapor products, fine cut tobacco products, cigars, pipes, smokeless tobacco products, and hookah and kretek products. The company provides reduced-risk products, including infused tobacco capsules and heated tobacco sticks. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, kidney and metabolism, immunity/inflammation, and central nervous system. Further, the company provides frozen and room-temperature products comprising frozen udon noodles, packed rice, and frozen okonomiyaki; and seasonings, including yeast extracts, assembled, kelp and bonito extracts, and oyster sauces. It offers its products under the Winston, Camel, MEVIUS, and LD brands. Japan Tobacco Inc. was founded in 1898 and is headquartered in Tokyo, Japan.
  • Symbol
    2914.TSE
  • Exchange
    TSE
  • Isin
    JP3726800000
  • Country
    Japan
  • Sector
    Consumer Defensive
  • Industry
    Tobacco
  • CEO
    Mr. Masamichi Terabatake
  • Headquarter
    Tokyo
  • Web site
    https://www.jt.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top